Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds.
By S. Grundy. Journal of the American College of Cardiology, 2006
717 citations recorded by the source corpus.
Subfields: History
View Paper: https://www.semanticscholar.org/paper/31c933fd2735ec1c8444c9aae6c779b1bcd4dae3
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In History
Citations in the corpus
- Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. (2014, background): “fibrinolysis, and endothelial function and has demonstrated that it may be transmitted genetically.(155,159,160) Several diagnos-”
- Pathophysiology of Type 2 Diabetes Mellitus (2020, background): “T2DM and IR impair metabolism and clearance of chylomicrons and VLDLs. Activation of CETP promotes an exchange of TG out of RLPs and incorporates CE from HDL and LDL particles leading to reduced levels of circulating HDL-C and an increase in the more atherogenic sdLDL particles (lower panel).”
- A Comprehensive Review on Metabolic Syndrome (2014, methodology): “On the other hand, the short-term (5–10 years) risk is better calculated using the classical algorithms (Framingham,REGICOR {RegistreGIronı́ del COR}), as they include age, sex, total cholesterol or LDL, and smoking [4].”
- Metabolic and cardiovascular adverse effects associated with antipsychotic drugs (2012, background): “The metabolic syndrome confers a 5–6-fold increase in the risk of developing type 2 diabetes mellitus and a 3–6-fold increase in the risk of death from coronary heart disease”
- The metabolic syndrome. (2008, background): “The risk for incident T2D is up to five times higher in individuals with the MetS compared with those without the syndrome (397, 408).”